Dr. Greg Page is a Managing Director in Navigant's Healthcare Dispute, Compliance & Investigations Practice. Greg brings more than 20 years of industrial management experience in both the Pharmaceutical and Biotech Life Science industries focusing on Quality Systems, Manufacturing and Laboratory Validations and FDA Regulatory Compliance with extensive experience in new business and product development, R&D, Quality Assurance, Quality Control, and FDA regulatory issues. Prior to joining Navigant, Greg obtained industrial management experience at the Director and Vice-President levels at Hoechst/Aventis, BASF, the NY Blood Center/Melville Biologics and VI Technologies. He has extensive FDA audit experience in areas including annual audits, licensing inspections & product meetings as well as 483 citations, warning letters and consent decree response and remediation program development.